A case of antiphospholipid syndrome, presenting as sinus vein thrombosis together with chronic active hepatitis, is reported in a 35-year-old woman.
Specific neurological syndromes have been reported in the presence of antiphospholipid antibodies.'"2 Chronic active hepatitis as part of the antiphospholipid syndrome has been described in only two patients. 34 We report the combination of sinus vein thrombosis together with chronic active hepatitis in a young woman with antiphospholipid syndrome. This patient was 13 months post-partum and still lactating; this may have contributed to her hypercoagulable state. Such a rare manifestation of the antiphospholipid syndrome has not previously been described.
Case report
Thirteen months post-partum and while still lactating, a 35-year-old woman, the mother of seven children, was hospitalised because of severe headaches and transient visual obscuration. She had a history of three spontaneous abortions. On physical examination her fever was 38.4°C and papilloedema with exudates and haemorrhages was noted. Visual acuity was 6/15 in the right eye and 6/12 in the left eye, pupils were equal with +4 response and no afferent pupil defect. Eye movements were normal. Goldmann perimetry showed enlarged blind spots. The erythrocyte sedimentation rate (ESR) At the same time, this patient developed chronic active hepatitis, which responded to steroids. The course of her disease is unusual, as the time of onset of the hepatitis is exactly defined and, despite the severe abnormalities on liver biopsy, she went into spontaneous biochemical remission for almost four months. The type of chronic hepatitis, however, remains obscure, as it does not fully conform to the classic type I autoimmune chronic active hepatitis, as she has anti-smooth-muscle antibodies and anticardiolipin antibodies, but no other auto-antibodies. Although the relationship between the antiphospholipid syndrome and Budd-Chiari syndrome has been previously described,6'7 there was no evidence of hepatic vein thrombosis either on Doppler ultrasound or CT or on liver biopsy. The relationship between the antiphospholipid syndrome and chronic active hepatitis, as in this patient, has been previously noted in only two other patients.3'4
The association of the antiphospholipid syndrome with chronic hepatitis, as in this patient, is extremely rare. The combination of cerebral sinus vein thrombosis and chronic active hepatitis, as a part of this syndrome, has not been previously described.8 Both manifestations of her disease, the sinus vein thrombosis and the chronic hepatitis, responded to treatment with steroids combined with anticoagulants. Clinical examination revealed him to be normotensive (140/90 mmHg) with an established left hemiparesis and sensory inattention. Physical examination was otherwise normal. Investigations included full blood count, urea, creatinine and electrolytes, fasting lipid profile, fasting glucose, HbAl, erythrocyte sedimentation rate, clotting screen, anticardiolipin antibodies, lupus anticoagulant, antithrombin III, C3, C4, CH50, protein C and protein S, VDRL, TPHA, autoimmune screen, electrocardiogram, chest X-ray, carotid Doppler studies and both transthoracic and transoesophageal echocardiography. All these investigations were normal.
Computed tomography of his brain was performed 24 hours after admission. This confirmed an infarct involving the right posterior external capsule, upper part of the internal capsule and corona radiata.
The patient was treated with low dose aspirin and entered a rehabilitation programme. He is making reasonable progress with intensive physiotherapy, but still has marked residual left-sided weakness.
Discussion
The first reports of acute stroke secondary to substance abuse were in the 1970s and were initially received with general scepticism, but the number of reported cases has greatly increased since 1983 with the introduction of the cocaine free-base, 'crack'.3 There are
